Home » Newsletters » BioWorld Science

BioWorld Science

May 22, 2001

View Archived Issues

Agile Therapeutics to evaluate once-weekly contraceptive patch in phase II trials

Zonagen's lead SPRM shows potential in treatment of endometriosis

Pipeline and program update provided by Texas Biotechnology

N-Acetylcysteine deserves further evaluation in Crohn's disease according to pilot study

CancerVax therapeutic vaccine significantly increases survival in late-stage cancers

Biota acquires NuMAX

Pharmacia's Vestra deemed not approvable by FDA

NitroMed's NO-donating proton pump inhibitors proven superior to lansoprazole in ulcer models

Promising preliminary results reported for AGI-1067 in postangioplasty restenosis

TAK-637, a selective, nonpeptide NK1 antagonist for IBS

Cambridge Antibody Technology reviews product pipeline

ETA antagonist delays disease progression, improves quality of life in late-stage prostate cancer

Company Profile: ALviva

Interim results of two Revimid studies presented at Myeloma Workshop

Vertex ICE inhibitor may have promise in inflammatory and autoimmune skin diseases

Preclinical studies support further testing of noscapine in malignant melanoma

Interferon Sciences licenses novel approach for prevention of tumor recurrence

ATS 2001: AWD-12-281 has beneficial effects on mucus secretion and lung neutrophilia

New research broadens understanding of mechanism of action for SAANDs

Obesity-related gene, methods for diagnosis and treatment of obesity, disclosed in recent patent

Adhesion receptor antagonists reported by Merck as useful in thrombotic disorders

Potential antidepressants in the GSK pipeline

Synthesis and use of azepinoindole PARP inhibitors in neurodegenerative disorders

Antiischemic adenosine agonists designed by Pfizer

Two patents issued for Lilly's new serotonergic piperidine derivatives

GlycoDesign and Leo select antithrombotic drug candidates

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...